NewslettersMammary Cell NewsSynergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via Regulating ADORA2A-EMT Related SignalingBy Noshin Noorjahan - July 6, 20230153Researchers evaluated whether toosendanin could enhance the efficacy of paclitaxel, a common chemotherapeutic agent, against TNBC.[Advanced Biology]Full Article